Genefluidics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Genefluidics

Access the complete profile.

Genefluidics Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325413 In-Vitro Diagnostic Substance Manufacturing 334516 Analytical Laboratory Instrument Manufacturing 541711 Research & Development in Biotechnology
Address	845 Meridian Street Irwindale, CA 91010

Note: Revenues for privately held companies are statistical evaluations.


Genefluidics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Genefluidics's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Genefluidics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Genefluidics Annual Revenue and Growth Rate

Genefluidics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Genefluidics's revenues are gauged from an analysis of company filings.

Genefluidics's Income Statement (based on Industry Averages)

Genefluidics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Genefluidics is developing and marketing. Genefluidics doesn't have any recent trademark applications, indicating Genefluidics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
A3 Diagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic media for bacteriological cultures; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic radiopharmaceutical agent for use in PET imaging; Diagnostic radiopharmaceutical preparations; Diagnostic reagents for medicinal use; Diagnostic test patch for application to the skin for determining allergic reactions; Diagnostic test patch for application to the skin for determining allergies; Contrasting agent for ultrasound diagnostic imaging; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; In-vivo diagnostic agent used for detection and monitoring of angiogenesis and anti-angiogenic therapy; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids; Medical diagnostic test strips for use in the field of susceptibility testing; Radio-isotope markers for therapeutic or diagnostic use; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Veterinary diagnostic reagents	12/20/2017
UTIMAX Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infections; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids	12/07/2017
BSIMAX Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infections; Diagnostic reagents for medicinal use; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids; Reagents and media for medical and veterinary diagnostic purposes; Veterinary diagnostic reagents	12/07/2017

See all trademarks and details in the Full Report.

Market Share of Genefluidics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Genefluidics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Genefluidics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
THERAGENT	Arcadia, CA	100
CHROMOLOGIC	Monrovia, CA	54
OAK CREST INSTITUTE OF SCIENCE	Monrovia, CA	54
TANNER RESEARCH	Duarte, CA	46
GLOBAL AEROSPACE	Duarte, CA	27
GENEFLUIDICS	Irwindale, CA	23

Future Competition: Genefluidics's Fastest Growing Competitors

These companies are in the same general field as Genefluidics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)